PUBLISHER: BCC Research | PRODUCT CODE: 1067758
PUBLISHER: BCC Research | PRODUCT CODE: 1067758
The global organ-on-a-chip market should reach $183.4 million by 2026 from $32.0 million in 2021 at a compound annual growth rate (CAGR) of 41.8% for the forecast period of 2021 to 2026.
The lung segment of global organ-on-a-chip market is expected to grow from $8.0 million in 2021 to $47.9 million in 2026 at a CAGR of 43.1% for the forecast period of 2021 to 2026.
The heart segment of global organ-on-a-chip market is expected to grow from $7.4 million in 2021 to $43.9 million in 2026 at a CAGR of 42.7% for the forecast period of 2021 to 2026.
The scope of this report covers various types of products available in the organ-on-a-chip market and potential application sectors in various industries. The organ-on-a-chip market is broken down into various segments. Revenue forecasts from 2019 to 2026 are given for each type, application, offering and end user. Revenue generated from the installation and maintenance of instruments has been excluded from the report. The application segment is characterized by various types, including drug discovery and development, toxicological research, and physiological model development, and by end-use industry, including academic and research institutes, pharmaceutical and biotechnology companies, cosmetics industry and other end users. By type market is segmented to liver, lung, kidney, heart and others. The report also focuses on regional segmentation of the market.
Further, it explains the major drivers and regional dynamics of the global market and current trends within the industry. It also includes information about the industry structure and competitive landscape as well as the impact of COVID-19 on the market. The report includes detailed profiles of the major players in the global organ-on-a-chip market.